Pneumonia Incidence in Rheumatic Disease Lowered With Primary Prophylaxis
In patients with rheumatic diseases, the incidence of pneumocystis pneumonia was reduced with primary prophylaxis with trimethoprim/sulfamethoxazole.
Vaccination
HPV Vaccine Does Not Increase Autoimmune Disease Risk
Researchers used registry data to evaluate the risk of autoimmune diseases over 6.5 years after exposure to HPV vaccines in adolescent and young adult women.
Pneumonia Vaccine Effectiveness Questioned in Rheumatoid Arthritis Patients
Study authors say results indicate vaccine may not be effective for pneumonia in patients with rheumatoid arthritis at high risk for infections.
Efficacy of Influenza Vaccination in Adults With SLE
Influenza vaccination reduced risk of hospitalization, pneumonia, ICU admission, in-hospital dialysis, and death.
$9 Billion Burden Linked to Vaccine-Preventable Diseases
Low rates of vaccine uptake are associated with increased costs both individually and societally.
Updated ACIP Seasonal Influenza Guidelines
A new reports issued updates the 2015-2016 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines
Statins Decreases Vaccine Efficacy Against Certain Influenza Strains
Statin use was associated with reduced VE against A(H3N2).
Nasal Influenza Vaccine No Longer Recommended by ACIP
The Advisory Committee on Immunization Practices (ACIP) of the CDC recommended against using the intranasal live quadrivalent influenza vaccine (FluMist® Quadrivalent, Astra Zeneca) in the U.S. for the 2016-2017 influenza season.
Addressing Altered Vaccine Immunogenicity and Low Vaccination Rates in Rheumatic Disease
Despite decades of research on the disproportionate impact of infection on those with rheumatic disease, patients in this population are less likely than those without rheumatic disease to undergo routine vaccination against preventable diseases.
Quadrivalent Influenza Vaccine Approved by the FDA
Studies have shown that vaccines made to protect against four flu viruses have a safety profile similar to seasonal flu vaccines made to protect against three viruses
